Screener
Silexion Therapeutics SLXN Q2 2025 earnings
Reported August 12, 2025 · Before market open
EPS-$4.32Miss by $1.17
EPS estimate-$3.15
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$9.10
Versus estimates
Diluted EPS
FAQ
- When did Silexion Therapeutics report Q2 2025 earnings?
- Silexion Therapeutics (SLXN) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Silexion Therapeutics's Q2 2025 revenue and EPS?
- Silexion Therapeutics reported eps of $-4.32 for Q2 2025.
- Did Silexion Therapeutics beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-3.15 by $1.17.
- How did Silexion Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 336.4% from $-0.99.
- Where can I find Silexion Therapeutics's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001178913-25-002784) and the 10-Q periodic report (0001178913-25-002804) directly on SEC EDGAR. The filing index links above go to sec.gov.
